MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-17-0059768
Resonate Pharmaceuticals Private Limited
Resonate Pharmaceuticals Private Limited - pharma in Virar, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹44.07 Lakh
▼ 17% YoY
Net profit · FY 2025
₹90,625
Net margin 2.1%
EBITDA · FY 2025
₹2.08 Lakh
EBITDA margin 4.7%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
10 yrs
Est. 2016
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Resonate Pharmaceuticals Private Limited
Data last updated:
Resonate Pharmaceuticals Private Limited is a private limited company based in Virar, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 03 May 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2016PTC280591. Its GSTIN is 27AAHCR7590L1ZM (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Dhaglaram Bhikaramji Choudhary and Hemalata Devi.
Its last annual general meeting (AGM) was held on 28 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 18 Poonam Imperial Building No. 1 Narangi Bypass Near Rustomjee School Dongre Village, Virar, Maharashtra, India – 401303.
As per the financials filed for FY 2025, the company reported a revenue of ₹44.07 Lakh, a decline of 17% compared to the previous year. For the same year it recorded a net profit of ₹90,625 (net margin 2.1%) and EBITDA of ₹2.08 Lakh (EBITDA margin 4.7%). Revenue has grown at a compounded annual rate (CAGR) of 5% over three years and 4% over five years.
Court records list 1 case involving the company, including 1 filed by the company; 1 case is pending.
Resonate Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-17-0059768). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U74999MH2016PTC280591
Registration Number 280591
Incorporation Date 03 May 2016
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 28 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MH-17-0059768
Recognitions & Rankings of Resonate Pharmaceuticals
Contact details
Resonate Pharmaceuticals Private Limited's registered office is in Virar, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address18 Poonam Imperial Building No. 1 Narangi Bypass Near Rustomjee School Dongre Village, Virar, Maharashtra, India – 401303
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Resonate Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Resonate Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Resonate Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Resonate Pharmaceuticals Private Limited, buy the company report.
Financials of Resonate Pharmaceuticals Private Limited
FY 2025 filings availableResonate Pharmaceuticals Private Limited reported revenue of ₹44.07 Lakh (down 17% YoY) for FY 2025.
Revenue · FY 2025
₹44.07 Lakh ▼ 17%
Net profit · FY 2025
₹90,625 margin 2.1%
EBITDA · FY 2025
₹2.08 Lakh margin 4.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 17%
3 years · compounded
▲ 5%
5 years · compounded
▲ 4%
EBITDA CAGR growth
1 year
▼ 55%
3 years · compounded
▼ 20%
5 years · compounded
▲ 1%
Revenue fell 17% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 4%. EBITDA fell 55% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.08 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹90,625 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.7% | ||||
| Net Profit Margin | 2.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Resonate Pharmaceuticals Private Limited, buy the company report.
Board of directors of Resonate Pharmaceuticals Private Limited
Resonate Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dhaglaram Bhikaramji Choudhary | Director | 03 May 2016 | 10 Years 5 Months | Current |
| Hemalata Devi | Director | 01 Sep 2018 | 8 Years 1 Months | Current |
Auditor
Resonate Pharmaceuticals Private Limited is audited by JOYMA R TUSCANO & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| JOYMA R TUSCANO & CO. | FY 2023 | 151606 |
Shareholding
The shareholding of Resonate Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Resonate Pharmaceuticals Private Limited, buy the company report.
Legal cases
Resonate Pharmaceuticals Private Limited has 1 court case on record: 1 filed by Resonate Pharmaceuticals. All case is pending.
Total cases
1
Filed by the company
1
Pending
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 0 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Thane, Maharashtra | Civil suit | Filed by the company against M/S. Aorta Life Sciences and Other 1 and 1 other | Pending |
To see the full case history of Resonate Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Resonate Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Resonate Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAHCR7590L1ZM | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Resonate Pharmaceuticals Private Limited, buy the company report.
Recent activity
Resonate Pharmaceuticals Private Limited has 4 board changes on record since 2016: 2 appointments and 2 cessations. The latest: Hemalata Devi ceased to be Additional Director on 28 Sep 2018.
AGM
Resonate Pharmaceuticals Private Limited last Annual general meeting of members was held on 28 Sep 2025 as per latest MCA records.
Filing
Resonate Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Ceased
Hemalata Devi ceased to be Additional Director.
Appointed
Hemalata Devi was appointed as Director.
Ceased
Girija Shanker Yadav ceased to be Director.
Appointed
Dhaglaram Bhikaramji Choudhary was appointed as Director.
Incorporation
03 May 2016
Resonate Pharmaceuticals Private Limited was registered on 03 May 2016 with Roc Mumbai & aged 10 years 5 months as per MCA records.
Frequently asked questions
Resonate Pharmaceuticals is an active private limited company based in Virar, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 03 May 2016 (10+ years old) and is registered under CIN U74999MH2016PTC280591.
Resonate Pharmaceuticals has 2 current directors:
- Dhaglaram Bhikaramji Choudhary - Director
- Hemalata Devi - Director
The latest financial statements of Resonate Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 28 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Resonate Pharmaceuticals is 27AAHCR7590L1ZM, registered in Maharashtra.
The CIN (Corporate Identification Number) of Resonate Pharmaceuticals is U74999MH2016PTC280591. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Resonate Pharmaceuticals has 1 court case on record: 1 filed by the company. 1 is pending.
Resonate Pharmaceuticals was incorporated on 03 May 2016, making it 10+ years old. It is registered with the Registrar of Companies, Mumbai.
Hemalata Devi ceased to be Additional Director on 28 Sep 2018. Hemalata Devi was appointed as Director on 01 Sep 2018. Girija Shanker Yadav ceased to be Director on 31 Aug 2018. Resonate Pharmaceuticals has 4 board changes on record in total.
Yes, Resonate Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-17-0059768).
The registered office of Resonate Pharmaceuticals is at 18 Poonam Imperial Building No. 1 Narangi Bypass Near Rustomjee School Dongre Village, Virar, Maharashtra, India – 401303.